Sharechat Logo

CarbonScape locks down minimum $400,000 in crowdfunding

Monday 17th November 2014

Text too small?

CarbonScape, the developers of a green alternative to coking coal used in steel making, has raised its minimum $400,000 target through online equity crowd funding.

The Christchurch based company is looking to raise up to $1.5 million through equity crowd funding platform, Snowball Effect, offering shares at 20 cents apiece with a minimum investment of $1,000 and will use the proceeds to fund the commercialisation of its "green coke".  Since the offer launched on Oct. 23, 104 investors have pledged $403,300, above the minimum target needed to lock in funds pledged from the crowd and has until Dec. 7 to raise further cash from the public. 

CarbonScape makes "green coke" from forestry waste as an alternative to coking coal, the high grade coal used in the steel industry. The business is looking to commercialise the product to capture a shift in the steel industry to more sustainable, fossil fuel free production.

New Zealand Steel, a subsidiary of Australia's BlueScope Steel, will be CarbonScape's first formal customer to take test samples of the green coke 12 months after the business secures its development capital.  The company has received support from government innovation entity, Callaghan Innovation.

With the minimum amount secured, CarbonScape will spend $132,000 on research and development, $90,000 on a green coke pilot plant design, $55,000 on two non-executive directors and $10,000 on lodging a new patent. The capital raised via Snowball is part of the company's wider financing plan to secure $3.5 million over the next 12 months, and it has already raised $2.9 million from previous offshore investors, it said.

According to its forecasts, based on the supply of 9,000 tonnes of green coke to NZ Steel, the business sees itself making an earnings before interest, tax, depreciation and amortisation loss of $484,000 in 2015, before turning to an Ebitda profit of $3.1 million on sales of $6.9 million in 2016. In 2017 it expects Ebitda of $5.5 million on $10.5 million in sales, and in 2018 it expects earnings to be $5.6 million on revenue of $10.7 million.

By 2021, the company projects revenue to have grown to $83 million, for a valuation of $415 million, on what it says is a realistic outlook. The company makes no mention of dividends in its offer documents or shareholders' agreement.

As at March 31 this year it had $4,737 cash on hand, which had increased to $105,000 at Sept. 30. Shareholders' equity was $195,043 as at Sept. 30.

Snowball is licensed under the new Financial Markets Conduct Act, which came into effect on April 1, providing a regime where projects can raise a maximum of $2 million, offering equity through crowd sourcing platforms. The licensing is part of the Financial Markets Authority's expanded brief to bolster New Zealand's capital markets, but the new platforms do carry risks for investors, with reduced compliance obligations for small capital raisings compared to companies listed on the NZX mainboard.

CarbonScape is Snowball's third equity crowd funding offer. It follows the success of Blenheim boutique brewer, Renaissance, which raised its maximum $700,000 of new capital from 287 investors in a week and a half, and 'The Patriarch' a new film to be directed by Lee Tamahori, which raised $453,800 from 181 people, just shy of its maximum $500,000 target.

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors